Market Neuron Logo
⚠ Disclaimer: This report is generated using AI tools and is for informational purposes only. It does not constitute investment advice. Please consult a registered financial advisor before making any investment decisions.

PIIND - Investment Analysis

Last Updated Time : 02 Aug 25, 12:58 am

Back to Investment List

Investment Rating: 4.5

📊 PI Industries Ltd (PIIND) — Long-Term Investment Analysis

✅ Strengths

ROCE (22.9%) & ROE (17.6%): Strong capital efficiency, ideal for compounding returns.

PEG Ratio (1.53): Reasonable valuation relative to growth, especially in specialty chemicals.

Debt-to-Equity (0.02): Near-zero leverage, excellent financial health.

Institutional Confidence: DII holdings increased by 1.78%, indicating domestic conviction.

Global Reach: Diversified revenue from agrochemicals and custom synthesis across Asia, Europe, and North America

1

2

.

⚠️ Weaknesses

Dividend Yield (0.38%): Minimal income generation.

Quarterly PAT Decline (-10.6%): Needs monitoring for trend reversal.

FII Holding Drop (-1.08%): Slight foreign investor caution.

📈 Ideal Entry Price Zone

Current Price: ₹4,250

52-Week Range: ₹2,951 – ₹4,804

Suggested Entry Zone: ₹3,800 – ₹4,050

This range aligns with technical support zones identified on TradingView and Moneycontrol

3

2

.

RSI at 62 and MACD positive suggest mild bullish momentum, but not overheated.

🧭 Long-Term Investment Outlook

PIIND is a high-quality compounder in the specialty chemicals and agrochemicals space. Its focus on innovation, global partnerships, and custom synthesis makes it a standout in the sector.

Price Targets (Based on Forecast Models)

4

Year Lower Target Upper Target

2025 ₹4,084 ₹4,247

2026 ₹4,545 ₹4,759

2027 ₹5,053 ₹5,324

2030 ₹6,648 ₹7,095

🛣️ Exit Strategy (If Already Holding)

If Bought Above ₹4,500

Hold for 2–3 years, reassess near ₹5,300–₹5,500.

Avoid panic selling unless fundamentals deteriorate.

If Bought Below ₹3,800

Hold for 5+ years, targeting ₹6,500–₹7,000.

Consider partial profit booking near ₹5,500.

Monitoring Metrics

ROE/ROCE trend (target >20%)

PEG ratio stability (<2 is ideal)

Quarterly PAT recovery

Export growth and pharma segment traction

Would you like a comparison with peers like Deepak Nitrite or SRF to benchmark PIIND’s valuation and growth potential?

1

stockanalysis.com

2

in.tradingview.com

3

www.moneycontrol.com

4

fincopanda.com

Edit in a page

Back to Investment List